InvestorsHub Logo

keltoi

05/21/12 9:26 AM

#2060 RE: bloomvest #2059

Good catch.I expected it this AM or tomorrow.Thet almost never post later than 7-8AM.They are running "late" today , but better late than never.

Thanks , Kelt

centillion

05/21/12 9:30 AM

#2061 RE: bloomvest #2059

Great News! I’m glad to see we are re-submitted and on the 30 day clock with FDA, but I especially liked Dr. Sylvia Holden’s quoted comment about Kevetrin having unparalleled magnitude of potential….Fantastic!

Ovidius

05/21/12 9:34 AM

#2062 RE: bloomvest #2059

Gotta love this line: As a stand-alone or combination front-line therapy, the magnitude of the potential of Kevetrin™ is simply unparalleled by anything that I have ever seen in the laboratory before.

Relentless4ever

05/21/12 11:32 AM

#2065 RE: bloomvest #2059

From the PR and I also believe in the 10Q from Friday:

'Primary endpoints for the study will be safety and tolerable dosing levels for a future Phase 2 clinical trial.'

What about efficacy in Phase I as they've previously stated before? Does anyone have any thoughts in this area as to whether phase I is just exclusively safety and tolerable dosing levels? It would be nice if this is a potential break-thru drug that it could be fast-track through all phases of development.

Drano

05/21/12 3:01 PM

#2069 RE: bloomvest #2059

Looks like this was so expected that it's not "news."

Patience must have its own rewards but I seem to be unaware of them....